NorthCrest Asset Manangement’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.9M | Sell |
53,957
-651
| -1% | -$167K | 0.37% | 79 |
|
|
2025
Q1 | $12.2M | Buy |
54,608
+1,575
| +3% | +$353K | 0.37% | 83 |
|
|
2024
Q4 | $12.1M | Buy |
53,033
+541
| +1% | +$124K | 0.36% | 82 |
|
|
2024
Q3 | $12.8M | Buy |
52,492
+1,378
| +3% | +$336K | 0.39% | 81 |
|
|
2024
Q2 | $9.78M | Sell |
51,114
-745
| -1% | -$143K | 0.32% | 89 |
|
|
2024
Q1 | $10.3M | Buy |
51,859
+828
| +2% | +$164K | 0.35% | 87 |
|
|
2023
Q4 | $8.78M | Buy |
51,031
+700
| +1% | +$120K | 0.33% | 91 |
|
|
2023
Q3 | $7.44M | Buy |
50,331
+1,322
| +3% | +$195K | 0.3% | 103 |
|
|
2023
Q2 | $10.7M | Sell |
49,009
-238
| -0.5% | -$52K | 0.42% | 79 |
|
|
2023
Q1 | $10.8M | Sell |
49,247
-169
| -0.3% | -$37K | 0.45% | 75 |
|
|
2022
Q4 | $10.3M | Sell |
49,416
-1,905
| -4% | -$396K | 0.58% | 59 |
|
|
2022
Q3 | $11.2M | Sell |
51,321
-2,454
| -5% | -$534K | 0.6% | 60 |
|
|
2022
Q2 | $11M | Buy |
53,775
+3,110
| +6% | +$638K | 0.56% | 65 |
|
|
2022
Q1 | $12.3M | Buy |
50,665
+1,582
| +3% | +$384K | 0.58% | 64 |
|
|
2021
Q4 | $12.8M | Buy |
+49,083
| New | +$12.8M | 0.7% | 44 |
|